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Introduction: Metronidazole (MET) and Miconazole (MIC) are antiprotozoal and 
imidazole antifungal agents, respectively. The aim of this study was to assess the 
usefulness of Fourier Transform Infrared micro-spectroscopy (FTIR-MSP) for 
discriminating and detecting spectral changes of mouse fetus liver tissue after mother’s 
exposure to concomitant use of MET and MIC. Methods and Results: The control 
group received only normal diet and the exposure groups received MET, MIC, and 
concomitant MET and MIC. The pregnant mice were anesthetized and their fetuses 
were surgically removed on gestation day 15. Fixative slides without any staining were 
put on KBr disc with a 1mm thick for IR micro spectroscopy. All information obtained 
from the spectra were analyzed using routine FTIR software. Based on our results, 
MET and MIC, alone and in combination together, have created some changes in the 
mice fetus liver biomolecules. Conclusion: FTIR biospectroscopy application in 
teratology is very challenging, but it has been accepted as a reliable technique; 
however, it is necessary to do more investigations. 
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Metronidazole (MET) (a nitro imidazole) is an 
antiprotozoal and antibacterial medication, selectively 
absorbed by anaerobic bacteria and sensitive protozoa 
[1-4]. Miconazole (MIC) is an imidazole antifungal 
agent, usually applied topically to the skin or mucous 
membranes to cure fungal infections [5-7]. MET and 
MIC are used for fungal and volvo vaginal infections 
like candidiasis, bacterial vaginitis, and trichomonas 
vaginitis. Concomitant use of MET and MIC during 
pregnancy , especially at the organogenesis period, 
causes polydactylyl and syndactylyl in the upper organs, 
defective skeletal system, cleft palate, rib deformity, 
skull deformation, and so on. [7-19].  
Fourier Transform Infrared micro-spectroscopy (FTIR-
MSP) is a powerful technique to provide sensitive and 
accurate measurement of biochemical changes in the 
biological cells and tissues. This approach provides 
structural information of biological molecules, such as 
proteins, nucleic acids, carbohydrates, and lipids, 
allowing detection, identification, and quantification of 
changes in these biomolecules. This technique is very 
rapid, non-destructive, and non-invasive for the sample, 
and requires low sample volume. This technique has 
also been used for the characterization and 
discrimination of diseased tissues from normal ones, 
particularly in cancer detection. Some of the most 
investigated tissues in this regard are cervix, lung, 
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breast, skin, gastrointestinal, brain, lymphoid, prostate, 
and colon. That is why the clinical applications of 
spectroscopic data have attracted attention of both the 
clinicians and the basic sciences researchers [20-32]. 
The ability of FTIR spectroscopy to determine the drugs 
induced abnormalities in fetus tissues has been shown in 
authors’ previous paper [31]. The present study aimed 
to determine the teratogenicity of MET and MIC in 
combination together by FTIR-MSP. 
2. Materials & Methods 
2.1. Preparation of the sample for FTIR-MSP  
Adult mice (10-12 weeks), weighed 20g, were 
purchased from Pasture institute, Iran. The laboratory 
NMRI mice were maintained under standard conditions 
(light period of 12 h/day, temperature (22°C), relative 
humidity (45%), and ventilation (15 air changes/hour)) 
with access to  water and libitum,  and all the 
experiments were carried out based on a protocol 
approved by local animal care ethical committee. MET 
and MIC were purchased from Daroopakhsh 
Pharmaceutical Company, Iran. After checking the 
vaginal plaque to identify the pregnant mice, they 
divided into four groups of ten animals eachand treated 
according to the method previously reported [33-36]: 1) 
the control group received only normal diet, group MET 
received Metronidazole (60 mg/kg), group MIC 
received Miconazole (60 mg/kg), and the last group 
(MET plus MIC) received 60 mg/kg of Metronidazole 
plus 60 mg/kg of Miconazole on the 9th day of gestation 
intraperitoneally. The fetuses were assessed on gestation 
day 15 for morphological and histological changes 
according to the reference [37], and then embedded in 
paraffin after fixation with Bouinn’s solution. 
Histological sections were prepared [29] by microtome 
instrument (10 μm), stained with haematoxylin and 
eosin )HE([38], and then examined under light 
microscopy for signs of fetal abnormalities. Slides 
without any staining were put on KBr disc with a 1mm 
thick for IR micro spectroscopy.  
2.2. FTIR-MSP  
FTIR measurements were carried out using WQF-510 
Fourier transform spectrometer (Rayleigh Optics, 
China) with a KBr beam splitter, equipped with a 
detector of DLaTGS (deuterated, L-alanine doped 
triglycine sulfate), IR microscope of µMAX (PIKE 
Technologies, USA), and a  KBr disc (13mm x 3mm), 
in the absorbance mode and all the spectra were scanned 
in the mid-IR range of 4000 to 400 cm
-1 




2.3. Data processing and analysis 
100 scans were co-added for each spectrum from 
several sites of the mouse fetus liver tissues sections to 
reach high signal to noise ratio (SNR). All information, 
obtained from the spectra, was analyzed using routine 
FTIR software. The average spectrum was calculated by 
averaging repetitive spectra (30 spectra per sample) and 
then employed for various mathematical manipulations. 
Baseline correction and normalization to the band at 
1545 cm
-1
 (amide II peak) as a reference for uniformity, 
were done for all the spectra [26] and second order 
derivatives were also calculated for specific regions. 
2.4. Statistics 
The tissue pathologic evaluated data from the treated 
fetus weight and the C-R length were analyzed using 
Graphpad Prism
©
 software. The findings of the MET, 
MIC, and MET plus MIC mouse fetus weight and C-R 
were analyzed using one-way variances analysis, 
followed by Tukey test (p<0.01). These findings were 
expressed as Mean±SD. One-way analysis of variances, 
followed by Tukey test (p<0.01), were done on FTIR 
spectral information using Origin Pro software (Version 
8.5.1) for checking the possibility of significant 
difference between the mentioned groups.  
3. Results and discussion 
3.1. Morphological studies 
Photomicrographs were prepared from the control, 
MET, MIC, and MET plus MIC treated tissue sections 
(Figure 1) and investigated by light microscope. 
Umbilical hernia, enlarged liver, and reducing the 
number of fetus were observed in MET plus MIC 
treated mouse fetus., There were some abnormalities in 
this group, such as brain developmental retardation, 
formation of heart out of mouse fetus body, deviation of 
the hands and feet, syndactylyl, hemoral, skull 
deformity, and short tail. 
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Figure 1. HE stained sections of the control, MET, MIC (Umbilical hernia, Enlarged liver) and MET plus MIC mouse fetus tissues (heart formation 
in out of body, Short tail, Syndactylyl , Brain developmental retardation).  
 
 
The weight (Fig. 2A) and the C-R length (Fig. 2B) of 
MET plus MIC treated mouse fetus were less than the 
other groups and there were significant difference 
between them with p<0.01. 
 
 
Figure 2. The weight of the mouse fetus (A), (control= 28.4gr; 
MET= 28.8 gr; MIC= 27.6gr; and MET plus MIC= 25.4gr); (p< 
0.01). * Significant difference versus the other group weights. The 
C-R of the mouse fetus (B), (control=11.5mm; MET= 11.4mm; 
MIC= 11.8mm; and MET plus MIC= 10.3mm), (p< 0.01). * 
Significant difference versus the other groups C-R. MET= 
Metronidazole and MIC= Miconazole. 
3.2. The drugs treated mouse fetus liver tissues 
(FTIR-MSP spectral characteristics)  
Figure 4 and 5 reveal a band at 1146 cm
-1
, due to 
the membrane-bound oligosaccharide C-OH bond, 
was disappeared in the MET treated fetus liver 
tissue, whereas it was present in the MIC treated 
and MET plus MIC treated fetus liver tissue. In the 
MIC treated and MET plus MIC treated fetus liver 
tissues, a band at 1107 cm
-1
,attributed to the ν 
(CO), ν (CC), and ring (polysaccharides, pectin) 
shifted, and also increased, and decreased, 
respectively, while it just reduced in fetus liver 
tissue, exposed to MET. A band at 1016 cm
-1
, due 
to the ν (CO), ν (CC), δ (OCH), and ring 
(polysaccharides, pectin), was appeared in the MIC 
treated fetus liver tissue but it was not present in 
the MET treated and MET plus MIC treated fetus 





due to the amid III and O-CH3 stretching of 
methoxy groups, respectively, decreased and 
shifted in the MET plus MIC treated fetus liver 
tissues, while it decreased without any shifting in 
the MET treated and MIC treated fetus liver 
tissues. A band at 1210 cm
-1
, related to the PO
-
2 
asymmetric (phosphate I), was appeared in the 
MET treated fetus liver tissue. Intensity at 1729 
cm
-1
, ascribed to the absorption band of fatty acid 
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ester band, increased and shifted in the MET plus 
MIC treated fetus liver tissue. A band at 1717 cm
-1
, 
due to the amid I, was disappeared in the MIC 
treated fetus liver tissue. Intensity at 1661 cm
-1
, 
due to the amid I, increased and shifted in the MET 




Figure 3. Mid-infrared spectra and the differential spectra (treated 
liver sections spectra-control sections spectra) of control and MET, 
MIC and MET plus MIC mice fetus liver tissue sections in the 1000–
3500 cm–1 wavenumber region. Baseline correction and normalization 
were done for all the spectra with a reference to the band at 1545 cm−1 
(amide II peak) for uniformity. 
 
A band at 1648 cm
-1
, related to the amid I, was present 
in the control and MIC treated fetus liver tissues, while 
it was disappeared in the MET treated and MET plus 
MIC treated fetus liver tissues. Intensity at 1593 cm
-1
, 
attributed to the C=N, NH2 adenine, decreased and 
shifted in the MIC treated fetus liver tissue. The bands 
at 1569 cm
-1
 and 1534 cm
-1
, owing to the amid II, were 
disappeared in the MET plus MIC treated fetus liver 
tissue,  while there were present in the control, MET 
treated, and MIC treated fetus liver tissues. Intensity at 
1549 cm
-1
, related to the amid II,  increased and shifted 
in the MET plus MIC treated fetus liver tissue, whereas 
it arised in the MIC treated and MET treated fetus liver 
tissues reduced. A band at 1522 cm
-1
, due to the 
stretching C=N and C=C, was not present in the control, 
MIC and MET treated fetus liver tissues, but was 
appeared in the MET plus MIC treated fetus liver tissue. 
A band at 2912 cm
-1
, attributed to the stretching 
vibrations of CH2 and CH3 of phospholipids, 
cholesterol, and creatine, was appeared in the MET 
treated and MET plus MIC treated fetus liver tissues, 
but was not present in the control and MIC treated fetus 
liver tissues. A band at 2823 cm
-1
, attributed to the 
stretching N-H (NH3+), was disappeared in the MIC 
treated and MET treated fetus liver tissues. A band at 
2804 cm
-1
, due to the stretching N-H (NH3+), was 
present in the control, but was disappeared in the other 




Figure 4. Mean FTIR spectra 2nd  derivative of mentioned groups 
mice fetus liver tissue sections in the 2600–3700 cm–1 wavenumber 
region. Baseline correction and normalization were done for all the 
spectra with a reference to the band at 1545 cm−1 (amide II peak) for 
uniformity. 
 
In the MIC treated and MET plus MIC treated fetus 
liver tissues, absorption at 1569 cm
-1
 (amide II), 1661 
cm
-1
 (amide I), 1678 cm
-1
 (stretching C=O vibrations 
that are H-bonded), 1694 cm
-1
 (a high frequency 
vibration of an antiparallel β-sheet of amide I), and 1745 
cm
-1
 (ester group (C=O) vibration of triglycerides) 
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increased, but in the MET treated fetus liver tissue 
reduced. In the MIC treated and MET treated fetus liver 
tissues, absorption at 1164 cm
-1
 (C-O stretching band of 
collagen (type I)), 1363 cm
-1
 (δ(CH2), ν (CC) 
(polysaccharides, pectin)), 1339 cm
-1
 (collagen), and 
1316 cm
-1
 (amide III) reduced, but in the MET plus 
MIC treated fetus liver tissue  increased . In the MIC 
treated and MET plus MIC treated fetus liver tissues, 
absorption at 1126 cm
-1
, attributed to the v(C-O), 
disaccharides, sucrose, v(C-O) + v(C-C), disaccharides, 
and sucrose increased, but in the MET treated fetus liver 
tissue remained unchanged. In the MIC treated and 
MET plus MIC treated fetus liver tissues, absorption at 
1515 cm
-1
 (amide II) was unchanged, but in the MET 












 rocking), and 1609 cm
-1
 (adenine 
vibration in DNA) reduced in all of them. A band at 
1380 cm
-1
 (δCH3 stretching C-O, deformation C-H, and 
deformation N-H) increased in all the groups.  









, and 2849 cm
-1
, mainly due to the stretching 
vibrations of CH2 and CH3 of phospholipids, 
cholesterol, and creatine, increased in all the groups. 
 
3.3. FTIR quantitative analysis of the mice fetus 
liver tissues: 
In order to make a quantitatively meaningful 
discrimination, three absorbance ratios of the peak 
heights between the control and the test groups at 
wavenumbers of 1124/1087, 1314/1234, and 1656/1634 
cm
-1
 were measured. The statistical evaluations for the 
control and the drugs treated mice fetus liver tissues 
were shown in figures 6-8 as means plot and mean 
comparison 
 
3.3.1. The absorbance ratio of 1124/1087 
Absorbance in the region of 1124/1087 is totally related 
to the presence of PO
-
2 symmetric (phosphate II), ν (Co), 
v (CC), and ring (polysaccharides, cellulose) groups. 
The mean values of the aforementioned ratio and the 
mean comparison plot for the different groups were 
observed in the figures 6-A and 6-B, respectively. 
Statistically significant differences were seen between 
all the groups (p<0.01). 
 
 
Figure 5. FTIR spectra of the control, MET, MIC and MET plus MIC 
groups mice fetus liver tissue sections in the various regions: 1000 to 
1150 cm−1 (A), 1200 to1350 cm−1 (B), 1600 to 1700 cm−1 (C). To 
present the spectral variations each spectrum were normalized to the 
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Figure. 6. Alterations in the ratios of 1124/1087 cm−1 (A) in the FTIR spectra of mouse fetus liver tissues. Results were presented as mean 
comparison plot; significant differences are marked in blue colors and non-significant differences are marked in green colors. One-way ANOVA 
followed by Tukey multiple comparisons were applied to analyze the data (p < 0.01). (For interpretation of the references to color in this figure 
legend, the reader is referred to the web version of this article.) 
 
3.3.2. The absorbance ratio of 1314/1234 
The absorbance ratio of 1314/1234 was applied for 
measuring the amide III band of proteins. Figures 7-A 
and 7-B show the mean values of this ratio and the 
mean comparison plot for the different groups, 
respectively. Clear separations were observed between 
the control and all the treated groups. Significant 
differences were seen between the control  and MET 
plus MIC treated, MET treated and MIC treated, MIC 
treated and MET plus MIC treated mouse fetus liver 
tissues. There was not any significant difference 
between the MET treated and MIC treated mouse 
fetus liver tissues and those of the control group. 
3.3.3. The absorbance ratio of 1656/1634 
 
The ratio of the contents of amide I to C=C uracil and 
C=O in the fetus liver was presented by the absorbance 
ratio of 1656/1634. , The mean comparison plot, shown 
in figure 8-D, exhibited significant differences between 
the mouse fetus liver tissues of the control group and 
those of the MET treated, MIC treated, and MET plus 
MIC treated groups. There was not any significant 
difference between the means of the above mentioned 
ratio in the MET treated and  MIC treated, MIC treated 
and MET plus MIC treated, and MET treated and MET 
plus MIC treated mouse fetus liver tissues. 
 
 
Figure. 7. Alterations in the ratios of 1314/1234 cm−1 (A), in the FTIR spectra of mouse fetus liver tissues. Means comparison plot applied for the 
results; significant and non-significant differences were displayed in blue and green colors, respectively. Data were analyzed by one-way ANOVA 
followed by Tukey multiple comparisons test (p < 0.01). (For interpretation of the references to color in this figure legend, the reader is referred to the 
web version of this article.) 
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Figure. 8. Alterations in the ratios of 1656/1634 cm−1 in the FTIR spectra of mouse fetus liver tissues. Means comparison plot were used for the 
results; significant differences and non-significant differences were displayed in blue and green colors, respectively. Data are analyzed by one-way 
ANOVA followed by Tukey multiple comparisons test (p < 0.01). (For interpretation of the references to color in this figure legend, the reader is 




FTIR-MSP effectively is a powerful tool for biomedical 
research applications. During the past decades, 
biospectroscopy has proved to be capable of detecting the 
infra-structural abnormalities of the biological tissues like 
cancer. We reported new application of FTIR-MSP for 
recognition  of molecular alterations in mice fetus tissues 
after exposure to Metronidazole, Miconazole, 
Levamisole, and Phenobarbital drugs in our previous 
researches [31, 39-41]. The potential of this method has 
been shown by detecting any degree of change in the 
fetus tissues even before any kind of morphological 
changes. However, any conclusion from a very 
complicated FTIR spectrum should be taken with caution, 
because of the complexity of the fetus matrix.  
Azole drugs (such as Metronidazole, Miconazole, and 
etc.) have side effects on the phospholipids of cell 
membranes and can inhibit endogenous respiration and 
morphogenetic transformation of yeasts to the mycelial 
form. So in this study, we have tried to detect spectral 
changes of mouse fetus liver tissue after mother’s 
exposure to concomitant use of  MET and MIC as an 
example of FTIR- MSP application in teratology. Liver 
tissues of the fetuses treated with the above mentioned 
drugs and control group were compared using 
photomicrographs after staining with Haematoxylin and 
Eosin. The weight and the C-R length of the MET plus 
MIC treated mouse fetus were less than the other groups 
and there were some adverse effects for them due to 
their exposure to MET and MIC alone. As shown in the 
figures 3-5, MET and MIC alone and in combination 
have created some changes in all of the mice fetus liver 
biomolecules. These drugs induced some important 
alterations in the fetus liver proteins, nucleic acids, and 
fatty acids. There were significant differences of nucleic 
acid ratio between all the groups treated by MET and 
MIC (alone and in combination) (Figure 6), while there 
was significant difference of amid III ratio between the 
MET plus MIC treated group with the other groups and 
its production decreased, but there was not any 
significant difference between the MET treated and 
MIC treated mouse fetus liver tissues and those of the 
control group (Figure 7). The last figure (Figure 8) 
showed significant difference of amide I ratio between 
the MET plus MIC treated and control groups and its 
production increased. 
FTIR biospectroscopy application in teratology is very 
challenging area, but it has been accepted as a reliable 
technique both for discovering the alterations and 
molecular mechanisms of fetus anomalies, caused by 
different agents; however, more investigations are 
required about its application. 
8 A. Ashtarinezhad et al., International Pharmacy Acta, 2019;2(1):e1 
 This open-access article is distributed under the terms of the Creative Commons Attribution Non Commercial 4.0 License (CC BY-NC 4.0). 
Acknowledgment 
This work was supported by the Pharmaceutical Sciences 
Research Center of Shahid Beheshti University of 
Medical Sciences. 
Conflict of interest 
There is no conflict of interest. 
References 
 
1. D.I. Edwards, Mechanisms of selective toxicity of metronidazole 
and other nitroimidazole drugs, The British journal of venereal 
diseases 56(5) (1980) 285-290.  
2. J. Cantu, D. Garcia-Cruz, Midline facial defect as a teratogenic 
effect of metronidazole, Birth defects: original article series  
(1982).  
3. A. Carvajal, A. Sánchez, G. Hurtarte, Metronidazole during 
pregnancy, International Journal of Gynecology & Obstetrics 48(3) 
(1995) 323-324.  
4. A. Bendesky, D. Menéndez, P. Ostrosky-Wegman, Is 
metronidazole carcinogenic?, Mutation Research/Reviews in 
Mutation Research 511(2) (2002) 133-144.  
5. C. Ito, Y. Shibutani, K. Inoue, K. Nakano, H. Ohnishi, 
Toxicological studies of miconazole. 2. Teratological studies of 
miconazole in rats, Iyakuhin Kenkyu 7 (1976) 367-376.  
6. M. Engelen, M.d. Bock, J. Hare, L. Goossens, Effectiveness of an 
otic product containing miconazole, polymyxin B and prednisolone 
in the treatment of canine otitis externa: multi-site field trial in the 
US and Canada, International Journal of Applied Research in 
Veterinary Medicine 8(1) (2010) 21-30.  
7. A.E. Czeizel, Z. Kazy, E. Puhó, Population‐based case‐control 
teratologic study of topical miconazole, Congenital Anom. 44(1) 
(2004) 41-45.  
8. International Agency for Research on Cancer (IARC) - Summaries 
& Evaluations, METRONIDAZOLE (Group 2B), IPCS INCHEM, 
1987, p. 250.  
9. Metronidazole intravenous infusion. Metronidazole PI Amended 12 
(2012). 
10. H.T. Sørensen, H. Larsen, E.S. Jensen, A.M. Thulstrup, H.C. 
Schønheyder, G.L. Nielsen, A. Czeizel, E.S. Group, Safety of 
metronidazole during pregnancy: a cohort study of risk of 
congenital abnormalities, preterm delivery and low birth weight in 
124 women, J. Antimicrob. Chemother. 44(6) (1999)  
11. M. Chacko, S. Bhide, Carcinogenicity, perinatal carcinogenicity 
and teratogenicity of low dose metronidazole (MNZ) in Swiss 
mice, J. Cancer Res. Clin. Oncol. 112(2) (1986) 135-140.  
12. F. Di Renzo, M.L. Broccia, E. Giavini, E. Menegola, Antifungal 
triazole derivative triadimefon induces ectopic maxillary cartilage 
by altering the morphogenesis of the first branchial arch, Birth 
Defects Research Part B: Developmental and Reproductive 
Toxicology 80(1) (2007) 2-11.  
13. G.M. Tiboni, F. Marotta, A. Del Corso, F. Giampietro, Defining critical 
periods for itraconazole-induced cleft palate, limb defects and axial 
skeletal malformations in the mouse, Toxicol. Lett. 167(1) (2006) 8-
18.  
14. O. Diav‐Citrin, S. Shechtman, T. Gotteiner, J. Arnon, A. Ornoy, 
Pregnancy outcome after gestational exposure to metronidazole: a 
prospective controlled cohort study, Teratology 63(5) (2001) 186-
192.  
15. T. Caro‐Patón, A. Carvajal, I. Martín de Diego, L.H. Martín‐Arias, 
A. Alvarez Requejo, E.R. Pinilla, Is metronidazole teratogenic? A 
meta‐analysis, Br. J. Clin. Pharmacol. 44(2) (1997) 179-182.  
16. P. Burtin, A. Taddio, O. Ariburnu, T.R. Einarson, G. Koren, 
Safety of metronidazole in pregnancy: a meta-analysis, Am. J. 
Obstet. Gynecol. 172(2) (1995) 525-529. DOI: 10.1016/0002-
9378(95)90567-7  
17. F. Greenberg, J.F. Reynolds, Possible metronidazole teratogenicity and 
clefting, American Journal of Medical Genetics Part A 22(4) 
(1985) 825-825.  
18. Z. Kazy, E. Puhó, A.E. Czeizel, Teratogenic potential of vaginal 
metronidazole treatment during pregnancy, European Journal of 
Obstetrics & Gynecology and Reproductive Biology 123(2) (2005) 
174-178.  
19. G.M. Tiboni, F. Marotta, A.P. Castigliego, Teratogenic effects in 
mouse fetuses subjected to the concurrent in utero exposure to 
miconazole and metronidazole, Reprod. Toxicol. 26(3) (2008) 254-
261. 
20. M.J. Walsh, T.G. Fellous, A. Hammiche, W.R. Lin, N.J. 
Fullwood, O. Grude, F. Bahrami, J.M. Nicholson, M. Cotte, J. 
Susini, Fourier transform infrared microspectroscopy identifies 
symmetric PO2− modifications as a marker of the putative stem 
cell region of human intestinal crypts, Stem Cells 26(1) (2008) 
108-118.  
21. I.I. Patel, D.A. Shearer, S.W. Fogarty, N.J. Fullwood, L. Quaroni, 
F.L. Martin, J. Weisz, Infrared microspectroscopy identifies 
biomolecular changes associated with chronic oxidative stress in 
mammary epithelium and stroma of breast tissues from healthy 
young women: Implications for latent stages of breast 
carcinogenesis, Cancer Biol. Ther. 15(2) (2014) 225-235.  
22. I.I. Patel, W.J. Harrison, J.G. Kerns, J. Filik, K. Wehbe, P.L. 
Carmichael, A.D. Scott, M.P. Philpott, M.D. Frogley, G. Cinque, 
Isolating stem cells in the inter-follicular epidermis employing 
synchrotron radiation-based Fourier-transform infrared 
microspectroscopy and focal plane array imaging, Anal. Bioanal. 
Chem. 404(6-7) (2012) 1745-1758.  
23. J.G. Kelly, A.A. Ahmadzai, P. Hermansen, M.A. Pitt, Z. Saidan, 
P.L. Martin-Hirsch, F.L. Martin, A biospectroscopic interrogation 
of fine needle aspirates points towards segregation between graded 
categories: an initial study towards diagnostic screening, Anal. 
Bioanal. Chem. 401(3) (2011) 957-967.  
24. Z. Movasaghi, S. Rehman, D.I. ur Rehman, Fourier transform 
infrared (FTIR) spectroscopy of biological tissues, Appl. 
Spectrosc. Rev. 43(2) (2008) 134-179.  
25. E. Bogomolny, M. Huleihel, Y. Suproun, R.K. Sahu, S. 
Mordechai, Early spectral changes of cellular malignant 
transformation using Fourier transform infrared 
microspectroscopy, J. Biomed. Opt. 12(2) (2007) 024003-024003-
9.  
26. M.J. Baker, J. Trevisan, P. Bassan, R. Bhargava, H.J. Butler, K.M. 
Dorling, P.R. Fielden, S.W. Fogarty, N.J. Fullwood, K.A. Heys, 
Using Fourier transform IR spectroscopy to analyze biological 
materials, Nat. Protoc. 9(8) (2014) 1771-1791.  
27. M. Miljković, B. Bird, K. Lenau, A.I. Mazur, M. Diem, Spectral 
Cytopathology: new aspects of data collection, manipulation and 
confounding effects, Analyst 138(14) (2013) 3975-3982.  
28. P. Bassan, A. Sachdeva, J. Lee, P. Gardner, Substrate 
contributions in micro-ATR of thin samples: implications for 
analysis of cells, tissue and biological fluids, Analyst 138(14) 
(2013) 4139-4146.  
29. V. Zohdi, D.R. Whelan, B.R. Wood, J.T. Pearson, K.R. Bambery, 
M.J. Black, Importance of tissue preparation methods in FTIR 
micro-spectroscopical analysis of biological tissues:‘Traps for new 
users’, PLoS One 10(2) (2015) e0116491.  
30. R. Bhargava, D.C. Fernandez, S.M. Hewitt, I.W. Levin, High 
throughput assessment of cells and tissues: Bayesian classification 
of spectral metrics from infrared vibrational spectroscopic imaging 
data, Biochim Biophys Acta Biomembr 1758(7) (2006) 830-845.  
31. A. Ashtarinezhad, F.H. Shirazi, H. Vatanpour, B. 
Mohamazadehasl, A. Panahyab, M. Nakhjavani, FTIR-
Microspectroscopy detection of Metronidazole teratogenic effects 
on mice fetus, Iran J Pharm Res 13(Suppl) (2014) 101.  
32. S. Olsztyńska-Janus, K. Szymborska-Małek, M. Gąsior-
Głogowska, T. Walski, M. Komorowska, W. Witkiewicz, C. 
Pezowicz, M. Kobielarz, S. Szotek, Spectroscopic techniques in 
the study of human tissues and their components. Part I: IR 
spectroscopy, Acta Bioeng Biomech 14 (2012) 101-115.  
Mice fetus liver tissue spectroscopic alterations following concomitant administration of Metronidazole & Miconazole  9 
 
This open-access article is distributed under the terms of the Creative Commons Attribution Non Commercial 4.0 License (CC BY-NC 4.0). 
33. F. Sullivan, P. McElhatton, Teratogenic acitivity of the 
antiepileptic drugs phenobarbital, phenytoin, and primidone in 
mice, Toxicol. Appl. Pharmacol. 34(2) (1975) 271-282.  
34. D.F. Bishop, A. Johansson, R. Phelps, A.A. Shady, M.C. Ramirez, 
M. Yasuda, A. Caro, R.J. Desnick, Uroporphyrinogen III synthase 
knock-in mice have the human congenital erythropoietic porphyria 
phenotype, including the characteristic light-induced cutaneous 
lesions, The American Journal of Human Genetics 78(4) (2006) 
645-658.  
35.N. Böhm, N. Noltemeyer, Excessive reversible phenobarbital 
induced nuclear DNA-polyploidization in the growing mouse liver, 
Histochemistry 72(1) (1981) 63-74.  
36. M.K. Mahabady, R. Ranjbar, A. Arzi, A. Papahn, H. Najafzadeh, 
A comparison study of effects of Echinacea extract and levamisole 
on phenytoin-induced cleft palate in mice, Regul. Toxicol. 
Pharmacol. 46(3) (2006) 163-166.  
37. G. Avwioro, Histochemical uses of haematoxylin—a review, 
JPCS 1 (2011) 24-34.  
38. I.o.L.A.R.C.o. Care, U.o.L. Animals, N.I.o.H.D.o.R. Resources, 
Guide for the care and use of laboratory animals, National 
Academies1985.  
39. A. Ashtarinezhad, A. Panahyab, B. Mohamadzadeh asl, H. 
Vatanpour, F. H. Shirazi, FTIR Determination of Miconazole 
Effects on Mice Fetus Brain Tissue, Iranian Journal of 
Pharmaceutical Sciences 10(2) (2015) 79-84.  
40. A. Ashtarinezhad, A. Panahyab, B. Mohamadzadehasl, H. 
Vatanpour, F.H. Shirazi, FTIR Microspectroscopy Reveals 
Chemical Changes in Mice Fetus Following Phenobarbital 
Administration, Iranian journal of pharmaceutical research: IJPR 
14(Suppl) (2015) 121.  
41. A. Ashtarinezhad, A. Panahyab, S. Shaterzadeh-Oskouei, H. 
Khoshniat, B. Mohamadzadehasl, F.H. Shirazi, Teratogenic study 
of phenobarbital and levamisole on mouse fetus liver tissue using 
biospectroscopy, J. Pharm. Biomed. Anal. 128 (2016) 174-183.  
 
